Navigation Links
Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
Date:3/6/2013

MOUNTAIN VIEW, Calif., March 6, 2013 /PRNewswire/ -- Decreasing exit opportunities and a challenging fundraising environment give pause to venture capitalists (VCs) in the North American healthcare industry. The increase in average deal value implies that VCs are choosing their companies prudently, despite reduction in the overall volume and value of deals.

New analysis from Frost & Sullivan's (http://www.financialservices.frost.com) Analysis of Venture Capital Investment Trends in the North American Healthcare Industry research reveals companies that have completed Phase 2 or are nearing Phase 3 of trials are attracting VC investors because of the shorter exit period and fewer failure risks.

If you are interested in more information on this analysis, please email Britni Myers , Corporate Communications, at britni.myers@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Government initiatives such as tax exemptions, lower interest rates and subsidies will go a long way," said Frost & Sullivan Business and Financial Services Research Analyst Dr. E. Saneesh.  "This support will prompt VCs to invest more in new products and technologies."

Owing to the current straitened circumstances, an increasing number of VCs are signing joint investment deals and forming partnerships with bigger healthcare companies, including pharmaceutical majors and medical technology companies.

However, the long drug development period, increasing clinical trial risks, stricter regulations, and decreasing initial public offerings (IPOs) make VCs skeptical about investing in biotechnology and pharmaceutical start-ups. Further, as the pharmaceutical and biotechnology sectors become mor
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
2. Frost & Sullivan Recognizes KAERs Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
3. Frost & Sullivan Recognizes GenePOCs Growth Backed by Strong Leadership and Technology Excellence
4. Frost & Sullivan Accolade for Swissrays Exceptional Dedication to its Customers
5. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
6. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
7. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
8. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
9. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
10. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
11. Gains from a Growing Patient Pool for Cardiac Rhythm Management Devices Offset by Lower Product Pricing, Observes Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. 17, 2014 ... a partnership in the fight against sarcoma. Under ... Alliance Suzanne Renee Leider Memorial Assistance Fund. ... to reimburse sarcoma patients for expenses directly related ... specialist. Scientific literature reinforces the importance of this ...
(Date:9/17/2014)... Sept. 17, 2014  Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that agreement has been reached with the ... design of a pivotal, Phase 3 clinical trial ... treatment of cutaneous T-cell lymphoma (CTCL).  ...
(Date:9/16/2014)... Massachusetts , 17. September 2014 ... HOLX ), hat heute die ... zur präanalytischen Probenverarbeitung, in Europa bekannt ... gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung der ... dass ineffiziente und fehlerbehaftete Arbeitsschritte bei ...
Breaking Medicine Technology:Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 2Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 3Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 4Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 5Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 6Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma 7Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... Inspiration Biopharmaceuticals, Inc. (Inspiration), the only ... of new treatment options for people with hemophilia, is ... as Chief Executive Officer. Mr. Butler replaces Michael Griffith, ... Officer and is retaining the title of President at ...
... 11, 2011 Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ... financial results on Tuesday, October 25, 2011 after the close ... conference call and slide presentation via webcast on Tuesday, October ... to discuss results and highlights of the third quarter, as ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 2Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer 3Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011 2
(Date:9/17/2014)... 17, 2014 With the development ... functions of adjusting human body physiology, preventing diseases, ... popularity with a variety of specific populations. In ... China reached RMB187.4 billion, up 12.0% year on ... , China's health product industry is composed of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 U.S. ... hospitals in the country, and three mesothelioma treatment ... treatment facilities, the mesothelioma law firm Baron ... Cancer Center, University of Texas MD Anderson Cancer ... by the publication. ( http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. ...
(Date:9/17/2014)... FL (PRWEB) September 17, 2014 ... with Ed Begley, Jr., scheduled to broadcast on ... via Discovery Channel. , In this episode, Innovations ... House of Freedom’s mission to provide each client ... and spiritual well being; using the principles of ...
(Date:9/17/2014)... 2014 Experienced dress company, Discount-Dress.com, announces ... selection of trendy black bridesmaid dresses. Furthermore, the company ... beautiful bridesmaid outfits. Readers can view more ... Discount-Dress.com is a famous brand of special occasion ... as well as revamped old editions, the supplier has ...
(Date:9/17/2014)... Headquartered in Baltimore, Maryland, Therapy Pets Unlimited ... , “The past two weeks have been amazing,” ... over 400 evaluators in 46 states, and we’re still ... and South Dakota and Vermont. And from there, we ... can visit.” , TPU provides one-of-a-kind treatment to facilities ...
Breaking Medicine News(10 mins):Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Health Food Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3
... of a molecular community in brain cells of mammals ... of new drugs. Researchers from Mount Sinai School // ... latest issue of journal Science. , ,The study ... within these communities enable groups of molecules and proteins ...
... the spice turmeric its yellow color, has come under ... its cancer-fighting abilities // . ,Researchers say ... block a key protein associated with esophageal cancer, known ... “ a shot in the arm for research,” ...
... time for meditation, yoga or even a trip to ... very compact these days. Thanks to the Chocolate-coated stress ... soon. ,The chocolate-like product comprises various nutraceutical herbs ... been developed by National Botanical Research Institute (NBRI), Lucknow., ...
... A protein that protects the body from tissue damage has ... protein helps the body's healthy cells survive the effects of ... found to encourage the growth of tumors in mice following ... urethane, a lung-specific carcinogen, on two sets of mice, which ...
... Mark A. Fishel, M.D., from the University of Washington, ... increase in Alzheimer’s disease. Moderately elevated levels of ... // in plasma and in cerebrospinal fluid and these ... was conducted in 16 healthy older adults ranging in ...
... from UCLA had found out that a deficient gene ... enzyme in the vision cycle that causes congenital blindness ... disease // called Leber congenital amaurosis is published in ... suggest that replacement of RPE65, which is lacking in ...
Cached Medicine News:Health News:The effects of Curcumin: a natural pigment in turmeric explored for its anti-cancer properties 2Health News:Enzyme Responsible For Congenital Blindness 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: